Naltrexone augments the effects of nicotine replacement therapy in female smokers

Joanne A. Byars, Kimberly Frost-Pineda, William Solomon Jacobs, Mark S. Gold

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Background. There is increased recognition that gender differences may influence outcomes and may modify vulnerability to tobacco addiction, severity of course and response to different treatments. We hypothesized that naltrexone, which has been used to successfully treat opioid and alcohol dependence, when combined with nicotine replacement therapy (NRT) and psychosocial therapy (PT) may enhance smoking cessation rates in women. Methods. Forty-four adult female smokers meeting DSM-IV criteria for nicotine dependence with expired carbon monoxide content of ≥ 15 ppm were randomly assigned in a double blind placebo controlled clinical trial of naltrexone 50 mg + NRT patch + psychosocial therapy (N + NRT + PT) (N = 12) or placebo + NRT patch + psychosocial therapy (P + N + PT) (N = 12) for 12 weeks. Results. Twelve weeks of treatment was completed by 54.5%. Smoking cessation among females who completed the 12 weeks for N + NRT + PT was 91.7% (11/12) and for P + NRT + PT was 50% (6/12). Conclusion. Naltrexone combined with NRT and psychosocial therapy appears to have a positive cessation effect on women and may be a new treatment option for recidivist female smokers.

Original languageEnglish (US)
Pages (from-to)49-60
Number of pages12
JournalJournal of Addictive Diseases
Volume24
Issue number2
DOIs
StatePublished - May 13 2005
Externally publishedYes

Fingerprint

Naltrexone
Nicotine
Therapeutics
Smoking Cessation
Placebos
Tobacco Use Disorder
Controlled Clinical Trials
Carbon Monoxide
Diagnostic and Statistical Manual of Mental Disorders
Opioid Analgesics
Alcoholism
Tobacco

Keywords

  • Gender differences
  • NRT
  • Smoking cessation
  • Women

ASJC Scopus subject areas

  • Medicine (miscellaneous)

Cite this

Naltrexone augments the effects of nicotine replacement therapy in female smokers. / Byars, Joanne A.; Frost-Pineda, Kimberly; Jacobs, William Solomon; Gold, Mark S.

In: Journal of Addictive Diseases, Vol. 24, No. 2, 13.05.2005, p. 49-60.

Research output: Contribution to journalArticle

Byars, Joanne A. ; Frost-Pineda, Kimberly ; Jacobs, William Solomon ; Gold, Mark S. / Naltrexone augments the effects of nicotine replacement therapy in female smokers. In: Journal of Addictive Diseases. 2005 ; Vol. 24, No. 2. pp. 49-60.
@article{26df3f5c56a949cf8daf15bc9a39e78b,
title = "Naltrexone augments the effects of nicotine replacement therapy in female smokers",
abstract = "Background. There is increased recognition that gender differences may influence outcomes and may modify vulnerability to tobacco addiction, severity of course and response to different treatments. We hypothesized that naltrexone, which has been used to successfully treat opioid and alcohol dependence, when combined with nicotine replacement therapy (NRT) and psychosocial therapy (PT) may enhance smoking cessation rates in women. Methods. Forty-four adult female smokers meeting DSM-IV criteria for nicotine dependence with expired carbon monoxide content of ≥ 15 ppm were randomly assigned in a double blind placebo controlled clinical trial of naltrexone 50 mg + NRT patch + psychosocial therapy (N + NRT + PT) (N = 12) or placebo + NRT patch + psychosocial therapy (P + N + PT) (N = 12) for 12 weeks. Results. Twelve weeks of treatment was completed by 54.5{\%}. Smoking cessation among females who completed the 12 weeks for N + NRT + PT was 91.7{\%} (11/12) and for P + NRT + PT was 50{\%} (6/12). Conclusion. Naltrexone combined with NRT and psychosocial therapy appears to have a positive cessation effect on women and may be a new treatment option for recidivist female smokers.",
keywords = "Gender differences, NRT, Smoking cessation, Women",
author = "Byars, {Joanne A.} and Kimberly Frost-Pineda and Jacobs, {William Solomon} and Gold, {Mark S.}",
year = "2005",
month = "5",
day = "13",
doi = "10.1300/J069v24n02_05",
language = "English (US)",
volume = "24",
pages = "49--60",
journal = "Journal of Addictive Diseases",
issn = "1055-0887",
publisher = "Routledge",
number = "2",

}

TY - JOUR

T1 - Naltrexone augments the effects of nicotine replacement therapy in female smokers

AU - Byars, Joanne A.

AU - Frost-Pineda, Kimberly

AU - Jacobs, William Solomon

AU - Gold, Mark S.

PY - 2005/5/13

Y1 - 2005/5/13

N2 - Background. There is increased recognition that gender differences may influence outcomes and may modify vulnerability to tobacco addiction, severity of course and response to different treatments. We hypothesized that naltrexone, which has been used to successfully treat opioid and alcohol dependence, when combined with nicotine replacement therapy (NRT) and psychosocial therapy (PT) may enhance smoking cessation rates in women. Methods. Forty-four adult female smokers meeting DSM-IV criteria for nicotine dependence with expired carbon monoxide content of ≥ 15 ppm were randomly assigned in a double blind placebo controlled clinical trial of naltrexone 50 mg + NRT patch + psychosocial therapy (N + NRT + PT) (N = 12) or placebo + NRT patch + psychosocial therapy (P + N + PT) (N = 12) for 12 weeks. Results. Twelve weeks of treatment was completed by 54.5%. Smoking cessation among females who completed the 12 weeks for N + NRT + PT was 91.7% (11/12) and for P + NRT + PT was 50% (6/12). Conclusion. Naltrexone combined with NRT and psychosocial therapy appears to have a positive cessation effect on women and may be a new treatment option for recidivist female smokers.

AB - Background. There is increased recognition that gender differences may influence outcomes and may modify vulnerability to tobacco addiction, severity of course and response to different treatments. We hypothesized that naltrexone, which has been used to successfully treat opioid and alcohol dependence, when combined with nicotine replacement therapy (NRT) and psychosocial therapy (PT) may enhance smoking cessation rates in women. Methods. Forty-four adult female smokers meeting DSM-IV criteria for nicotine dependence with expired carbon monoxide content of ≥ 15 ppm were randomly assigned in a double blind placebo controlled clinical trial of naltrexone 50 mg + NRT patch + psychosocial therapy (N + NRT + PT) (N = 12) or placebo + NRT patch + psychosocial therapy (P + N + PT) (N = 12) for 12 weeks. Results. Twelve weeks of treatment was completed by 54.5%. Smoking cessation among females who completed the 12 weeks for N + NRT + PT was 91.7% (11/12) and for P + NRT + PT was 50% (6/12). Conclusion. Naltrexone combined with NRT and psychosocial therapy appears to have a positive cessation effect on women and may be a new treatment option for recidivist female smokers.

KW - Gender differences

KW - NRT

KW - Smoking cessation

KW - Women

UR - http://www.scopus.com/inward/record.url?scp=18044377228&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=18044377228&partnerID=8YFLogxK

U2 - 10.1300/J069v24n02_05

DO - 10.1300/J069v24n02_05

M3 - Article

C2 - 15784523

AN - SCOPUS:18044377228

VL - 24

SP - 49

EP - 60

JO - Journal of Addictive Diseases

JF - Journal of Addictive Diseases

SN - 1055-0887

IS - 2

ER -